Market Cap (In TWD)
3.41 Billion
Revenue (In TWD)
1.83 Billion
Net Income (In TWD)
274.82 Million
Avg. Volume
19.87 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 125.5-177.0
- PE
- -
- EPS
- -
- Beta Value
- 0.431
- ISIN
- TW0008279001
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Wei Ren Chen
- Employee Count
- -
- Website
- https://www.syngen.com.tw
- Ipo Date
- 2014-11-14
- Details
- Syngen Biotech Co.,Ltd. engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicine. It also offers contract manufacturing; science-based and bio active pharmaceutical ingredients; and private labelling. In addition, the company provides organic food OEM/ODM, explosion proof extraction, brand agency, and wholesale distribution services. The company was founded in 1988 and is based in Tainan City, Taiwan.
More Stocks
-
EMIL
-
BAYN
-
2393
-
9202ANA Holdings Inc.
9202
-
3768Riskmonster.com
3768
-
NNCHY
-
BPAC3Banco BTG Pactual S.A.
BPAC3
-
002114